Medical management of eating disorders: an update.
Journal
Current opinion in psychiatry
ISSN: 1473-6578
Titre abrégé: Curr Opin Psychiatry
Pays: United States
ID NLM: 8809880
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
pubmed:
15
9
2020
medline:
15
5
2021
entrez:
14
9
2020
Statut:
ppublish
Résumé
Eating disorders are associated with numerous medical complications. The aim of this study was to review recent progress in improving the medical management of patients with eating disorders. With close medical monitoring and electrolyte supplementation, accelerated refeeding protocols improve weight restoration without increasing the risk of refeeding syndrome. Olanzapine improves weight restoration better than placebo, without leading to adverse metabolic effects seen in individuals not in starvation. Alterations of the gut microbiome in anorexia nervosa have been demonstrated, but their clinical relevance remains unclear. Medical complications of eating disorders may facilitate the first contact with health professionals and treatment initiation. Medical complications of anorexia nervosa generally occur due to starvation, malnutrition and their associated physiological effects, whereas medical complications of bulimia nervosa are generally due to purging behaviors. Most medical complications in patients with binge eating disorder are secondary to obesity. Most medical complications of eating disorders can be effectively treated with nutritional management, weight normalization and the termination of purging behaviors. In summary, eating disorders are associated with many medical complications that have to be carefully assessed and managed as early as possible to improve long-term outcomes.
Identifiants
pubmed: 32925184
doi: 10.1097/YCO.0000000000000653
pii: 00001504-202011000-00006
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
542-553Références
Treasure J, Duarte TA, Schmidt U. Eating disorders. Lancet 2020; 395:899–911.
Arcelus J, Mitchell AJ, Wales J, Nielsen S. Mortality rates in patients with anorexia nervosa and other eating disorders: a meta-analysis of 36 studies. Arch Gen Psychiatry 2011; 68:724–731.
Sullivan PF. Mortality in anorexia nervosa. Am J Psychiatry 1995; 152:1073–1074.
Mehler PS, Blalock DV, Walden K, et al. Medical findings in 1,026 consecutive adult inpatient–residential eating disordered patients. Int J Eat Disord 2018; 51:305–313.
Krantz MJ, Blalock DV, Tanganyika K, et al. Is QTc-interval prolongation an inherent feature of eating disorders? A cohort study. Am J Med 2020; S0002-9343(20)30197-2. doi:10.1016/j.amjmed.2020.02.015.
doi: 10.1016/j.amjmed.2020.02.015
Oudman E, Wijnia JW, Oey MJ, et al. Preventing Wernicke's encephalopathy in anorexia nervosa: a systematic review. Psychiatry Clin Neurosci 2018; 72:774–779.
Friedli N, Stanga Z, Sobotka L, et al. Revisiting the refeeding syndrome: results of a systematic review. Nutrition 2017; 35:151–160.
Luong Kvq, Nguyen LTH. The impact of thiamine treatment in the diabetes mellitus. J Clin Med Res 2012; 4:153.
Mehler PS, Brown C. Anorexia nervosa–medical complications. J Eat Disord 2015; 3:11.
Riedlinger C, Schmidt G, Weiland A, et al. Which symptoms, complaints and complications of the gastrointestinal tract occur in patients with eating disorders? A systematic review and quantitative analysis. Front Psychiatry 2020; 11:195.
Schalla MA, Stengel A. Gastrointestinal alterations in anorexia nervosa – a systematic review. Eur Eat Disord Rev 2019; 27:447–461.
Correll C. From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics. Eur Psychiatry 2010; 25:S12–S21.
Dalton B, Bartholdy S, Robinson L, et al. A meta-analysis of cytokine concentrations in eating disorders. J Psychiatr Res 2018; 103:252–264.
Solmi M, Veronese N, Manzato E, et al. Oxidative stress and antioxidant levels in patients with anorexia nervosa: a systematic review and exploratory meta-analysis. Int J Eat Disord 2015; 48:826–841.
Solmi M, Veronese N, Favaro A, et al. Inflammatory cytokines and anorexia nervosa: a meta-analysis of cross-sectional and longitudinal studies. Psychoneuroendocrinology 2015; 51:237–252.
Peebles R, Sieke EH. Medical complications of eating disorders in youth. Child Adolesc Psychiatr Clin N Am 2019; 28:593–615.
Kärkkäinen U, Mustelin L, Raevuori A, et al. Do disordered eating behaviours have long-term health-related consequences? Eur Eat Disord Rev 2018; 26:22–28.
Udo T, Grilo CM. Psychiatric and medical correlates of DSM-5 eating disorders in a nationally representative sample of adults in the United States. Int J Eat Disord 2019; 52:42–50.
Tith RM, Paradis G, Potter BJ, et al. Association of bulimia nervosa with long-term risk of cardiovascular disease and mortality among women. JAMA Psychiatry 2020; 77:44–51.
Tabler J, Utz RL, Smith KR, et al. Variation in reproductive outcomes of women with histories of bulimia nervosa, anorexia nervosa, or eating disorder not otherwise specified relative to the general population and closest-aged sisters. Int J Eat Disord 2018; 51:102–111.
Mitchell JE. Medical comorbidity and medical complications associated with binge-eating disorder. Int J Eat Disord 2016; 49:319–323.
Garber AK, Sawyer SM, Golden NH, et al. A systematic review of approaches to refeeding in patients with anorexia nervosa. Int J Eat Disord 2016; 49:293–310.
Koerner T, Haas V, Heese J, et al. Outcomes of an accelerated inpatient refeeding protocol in 103 extremely underweight adults with anorexia nervosa at a specialized clinic in Prien, Germany. J Clin Med 2020; 9:1535.
Garber AK. A few steps closer to answering the unanswered questions about higher calorie refeeding. J Eat Disord 2017; 5:8.
Haas V, Kohn MR, Koerner T, et al. Evidence-based clinical guide to facilitate accelerated re-nutrition of patients with anorexia nervosa. J Am Acad Child Adolesc Psychiatry. (In press).
Kohn MR, Madden S, Clarke SD. Refeeding in anorexia nervosa: increased safety and efficiency through understanding the pathophysiology of protein calorie malnutrition. Curr Opin Pediatr 2011; 23:390–394.
Matthews K, Hill J, Jeffrey S, et al. A higher-calorie refeeding protocol does not increase adverse outcomes in adult patients with eating disorders. J Acad Nutr Diet 2018; 118:1450–1463.
Rizzo SM, Douglas JW, Lawrence JC. Enteral nutrition via nasogastric tube for refeeding patients with anorexia nervosa: a systematic review. Nutr Clin Pract 2019; 34:359–370.
Rigaud D, Brondel L, Poupard AT, et al. A randomized trial on the efficacy of a 2-month tube feeding regimen in anorexia nervosa: a 1-year follow-up study. Clin Nutr 2007; 26:421–429.
Hanachi M, Dicembre M, Rives-Lange C, et al. Micronutrients deficiencies in 374 severely malnourished anorexia nervosa inpatients. Nutrients 2019; 11:792.
Suzuki H, Asakawa A, B Li J, et al. Zinc as an appetite stimulator-the possible role of zinc in the progression of diseases such as cachexia and sarcopenia. Recent Pat Food Nutr Agric 2011; 3:226–231.
Franques J, Chiche L, Mathis S. Sensory neuronopathy revealing severe vitamin B12 deficiency in a patient with anorexia nervosa: an often-forgotten reversible cause. Nutrients 2017; 9:281.
Solmi M, Veronese N, Correll C, et al. Bone mineral density, osteoporosis, and fractures among people with eating disorders: a systematic review and meta-analysis. Acta Psychiatr Scand 2016; 133:341–351.
Schorr M, Miller KK. The endocrine manifestations of anorexia nervosa: mechanisms and management. Nat Rev Endocrinol 2017; 13:174.
Maïmoun L, Renard E, Lefebvre P, et al. Oral contraceptives partially protect from bone loss in young women with anorexia nervosa. Fertil Steril 2019; 111:1020–1029.e2.
Lam YY, Maguire S, Palacios T, Caterson ID. Are the gut bacteria telling us to eat or not to eat? Reviewing the role of gut microbiota in the etiology, disease progression and treatment of eating disorders. Nutrients 2017; 9:602.
Dominique M, Legrand R, Galmiche M, et al. Changes in microbiota and bacterial protein caseinolytic peptidase B during food restriction in mice: relevance for the onset and perpetuation of anorexia nervosa. Nutrients 2019; 11:2514.
Seitz J, Trinh S, Herpertz-Dahlmann B. The microbiome and eating disorders. Psychiatr Clin North Am 2019; 42:93–103.
Kleiman SC, Watson HJ, Bulik-Sullivan EC, et al. The intestinal microbiota in acute anorexia nervosa and during renourishment: relationship to depression, anxiety, and eating disorder psychopathology. Psychosom Med 2015; 77:969.
Himmerich H, Treasure J. Psychopharmacological advances in eating disorders. Expert Rev Clin Pharmacol 2018; 11:95–108.
Crow SJ. Pharmacologic treatment of eating disorders. Psychiatr Clin North Am 2019; 42:253–262.
Kishi T, Kafantaris V, Sunday S, et al. Are antipsychotics effective for the treatment of anorexia nervosa? Results from a systematic review and meta-analysis. J Clin Psychiatry 2012; 73:e757–e766.
Attia E, Steinglass JE, Walsh BT, et al. Olanzapine versus placebo in adult outpatients with anorexia nervosa: a randomized clinical trial. Am J Psychiatry 2019; 176:449–456.
Solmi M, Murru A, Pacchiarotti I, et al. Safety, tolerability, and risks associated with first-and second-generation antipsychotics: a state-of-the-art clinical review. Ther Clin Risk Manag 2017; 13:757.
Firth J, Siddiqi N, Koyanagi A, et al. The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. Lancet Psychiatry 2019; 6:675–712.
Voderholzer U, Hessler-Kaufmann JB, Lustig L, Läge D. Comparing severity and qualitative facets of depression between eating disorders and depressive disorders: analysis of routine data. J Affect Disord 2019; 257:758–764.
Herpertz S, Herpertz-Dahlmann B, Fichter M, et al. S3-Leitlinie Diagnostik und Behandlung der Essstörungen. Springer Verlag, Berlin: Springer-Verlag Berlin Heidelberg; 2019.